Research groups
Joseph Clarke
Postdoctoral Scientist
I am a Postdoctoral Scientist working with Professor Simon Davis' T-Cell Biology group and Dr. Sumana Sharma's Mechanistic T-Cell Genomics Group within the MRC Translational Immune Discovery Unit (TIDU). Broadly, I am interested in how interactions at the cell membrane influence T-cell decision-making. My current research focuses on uncovering the signalling networks that enable inhibitory receptor activity in CD8+ T-cells and identifying genetic mediators of enhanced T-cell function, persistence, and fitness, using high-throughput CRISPR-Cas9 gene editing platforms to address these key questions.
Previously, I completed my PhD in April 2023 at the University of Birmingham, in the laboratories of Professor David Wraith and Professor Alicia El Haj, where I investigated the triggering mechanisms of the T-cell receptor (TCR).
Recent publications
Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms.
Journal article
Barker CG. et al, (2026), Mol Syst Biol
Signalome-wide mapping of the NFκB pathway in T-cells reveals novel targets for immunotherapy
Preprint
Clarke J. et al, (2026)
Remote Force Modulation of the T-Cell Receptor Reveals an NFAT-Threshold for CD4+ T-Cell Activation.
Journal article
Clarke J. et al, (2025), Eur J Immunol, 55
Remote force modulation of the T-cell receptor reveals an NFAT-threshold for CD4 + T cell activation
Preprint
Clarke J. et al, (2024)
igh-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells.
Journal article
Sharma S. et al, (2024), Life Sci Alliance, 7
